SOM Biotech will participate in the Euronext webinar “Finance your tech company´s growth through capital markets” next June 25th.
Raul Insa, CEO of SOM Biotech, will be a keynote speaker sharing his experience and views on financing alternatives for a biotech company.
Raul Insa: “As CEO and founding partner of a growing biotech company, I have led different initiatives to raise funding at different stages of SOM Biotech´s growth. Currently, the company aims to strengthen its financing strategy and incorporate new qualified investors to accompany us in a new phase of expansion. Capital markets, and specially Euronext, offer ideal financing options for technology companies that want to attract investors specialized in technology and innovation.”
El equipo de investigadores observó cambios en el...
El gen AtCDF3 promueve una mayor producción de az...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del si...
Una investigación liderada por científicos del IIBB-CSIC y del CIBER...
